WILLIAM MCKEE
CIK 1237262 · Chief Financial Officer · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$676.5K
Companies
8
Total Filings
46
Lifetime Open-Market Net
-$763.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASRT | Director | 27,936 | $23.48 | $655.9K | -$220.9K | 12 | 2026-05-06 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | — | $2.11 | — | $0 | 4 | 2022-06-17 |
| CCCC | Chief Financial Officer | 5,263 | $3.90 | $20.5K | $100.0K | 1 | 2020-10-06 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 17,949 | $1.51 | $27.1K | $0 | 5 | 2019-06-07 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | — | — | — | $0 | 3 | 2018-05-10 |
| Dare Bioscience, Inc. (CERU) Delisted | Director | 3,418 | — | — | $0 | 4 | 2017-01-05 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 0 | — | — | -$642.2K | 9 | 2015-01-30 |
| BARR PHARMACEUTICALS INC (BRL) Delisted | EVP, CFO | 8,977 | — | — | $0 | 7 | 2008-12-19 |
Recent Filings · Page 3 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-08-16 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-30 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-05 | Dare Bioscience, Inc. (CERU) Delisted | Grant (A) | +1,948 | $1.5K | EDGAR |
| 2016-10-20 | Dare Bioscience, Inc. (CERU) Delisted | Grant (A) | +1,470 | $1.5K | EDGAR |
| 2016-06-24 | Dare Bioscience, Inc. (CERU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-09 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-30 | Dare Bioscience, Inc. (CERU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-30 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Other (J) | −10,000 | -$365.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.